Feedback / Questions
VG081821 - Vimgreen Pharma
https://www.prnewswire.com/news-releases/vimgreen-completes-enrollment-of-its-phase-2-clinical-trial-evaluating-vg081821ac-for-the-treatment-of-parkinsons-disease-302223602.html
Aug 15, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next